CIK 0002044725
- Emerging growth company
Evommune, Inc.
Sign in to watch- Ticker
- EVMN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850742575
- Phone
- +1 650-223-7745
- Business address
- 1891 PAGE MILL RD, PALO ALTO, CA
- 4 Planned sale Chief Business & Legal Officer sold 14,223 shares at $22.83 ($324,711)
- 4 Planned sale Chief Financial Officer sold 18,175 shares at $22.84 ($415,117)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 358,680 shares (grant or award)
- 4 Grant or award Director acquired 358,680 shares (grant or award)
- 4 Grant or award Director acquired 35,868 shares (grant or award)
- 4 Open-market buy Director bought 1,000 shares at $17.35 ($17,350)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President & CEO gave up 28,138 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 7,513 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business & Legal Officer gave up 13,624 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Operations gave up 5,074 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 13,290 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,478 shares (to pay taxes)
- 4 Conversion Director acquired 3,367,975 shares (conversion)
Page 2 of 4 · 74 filings